VSN-16, a cannabinoid receptor agonist, is used potentially for the treatment of spasticity in multiple sclerosis.

863713-78-4

C18H26N2O3

318.41

VSN 16R;VSN16R;VSN-16R;VSN-16

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years